跳至主要内容
临床试验/NCT03123419
NCT03123419撤回不适用

Gardasil Administration

St. Louis University2 个研究点 分布在 1 个国家开始时间: 2018年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Increase HPV-9 vaccine administration rates

研究概览

简要总结

The purpose of the Gardasil study is to increase the rates of Gardasil vaccination at a maternal fetal Care Center. This will be done by reminding patients via text to come for follow up vaccine appointments.

详细描述

Patients will be screened in center for history of Gardasil vaccination. If the patient has not received the vaccination series they will be counseled/educated (standard of care [SOC }) and offered the vaccine series. If the patient agrees to the vaccination, they will then be offered participation in this study, (consent will be reviewed and signed) and they will receive the first vaccination at this visit, administered according to standard protocol. The patient will then be scheduled for two follow up vaccination appointments. The second vaccination will be given 2 months after the first vaccine and the third will be given 4 months after the second vaccination in accordance with the Gardasil vaccine guidelines. -SOC

The patients will receive a total of two texts during the study entirety. The two texts will be appointment reminders for the second and third vaccination, sent 1 week prior to the next appointment. This is study related.

Data collection Data will be collected using a data collection sheet. The investigators will record date of first vaccine administration and adherence to follow up.vaccinations.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
9 Years 至 26 Years(Child, Adult)
性别
Female
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Vaccine

Other

All patients who consent to be in the study will receive Appointment reminders.

干预措施: Appointment reminders (Behavioral)

结局指标

主要结局

Increase HPV-9 vaccine administration rates

时间窗: through study completion, an average of 1 year

The text reminder messages will increase HPV-9 vaccine administration rates

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Sarah Hostetter, MD

Principal Investigator

St. Louis University

研究点 (2)

Loading locations...

相似试验